These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 167445)

  • 41. Profile of intracytoplasmic lysozyme in normal tissues, myeloproliferative disorders, hairy cell leukemia, and other pathologic processes. An immunoperoxidase study of paraffin sections and smears.
    Pinkus GS; Said JW
    Am J Pathol; 1977 Nov; 89(2):351-66. PubMed ID: 335890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E
    Cancer Res; 1986 Feb; 46(2):975-80. PubMed ID: 3455679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on muramidase in hematologic disorders. I. Serum muramidase and serum lactic dehydrogenase in leukemia.
    Levi JA; Speden JB; Vincent PC; Gunz FW
    Cancer; 1973 Apr; 31(4):939-47. PubMed ID: 4513296
    [No Abstract]   [Full Text] [Related]  

  • 46. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutrophil defect in multiple myeloma. Studies on intraneutrophilic lysozyme in multiple myeloma and malignant lymphoma.
    Karle H; Hansen NE; Plesner T
    Scand J Haematol; 1976 Jul; 17(1):62-70. PubMed ID: 959776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The interrelation of serum lysozyme level and cytoplasmic lysozyme level].
    Okano K; Yamamoto K; Ueda J; Fujii Y; Yonehara Y; Araki M
    Rinsho Byori; 1994 Mar; 42(3):278-82. PubMed ID: 8152164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical and experimental studies on aldolase and its isoenzymes in leukemia and allied hematological disorders (author's transl)].
    Sakurada K
    Hokkaido Igaku Zasshi; 1979 Sep; 54(5):501-31. PubMed ID: 294406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Significance of muramidase (lysozyme) determination for the diagnosis of leukemia].
    Asamer H
    Dtsch Med Wochenschr; 1971 May; 96(19):829-30. PubMed ID: 5280412
    [No Abstract]   [Full Text] [Related]  

  • 51. [Contribution of a hematologic cytogenetic laboratory to the diagnosis, classification and prognosis of various hematologic malignancies].
    Debray J; Krulik M; Smadja NV
    Bull Acad Natl Med; 1992 May; 176(5):629-38; discussion 638-40. PubMed ID: 1422868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reticulocytes in haematological disorders.
    d'Onofrio G; Kuse R; Foures C; Jou JM; Pradella M; Zini G
    Clin Lab Haematol; 1996 Dec; 18 Suppl 1():29-34. PubMed ID: 9054716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic and prognostic value of chromosome studies in cancer.
    Nowell PC
    Ann Clin Lab Sci; 1974; 4(4):234-40. PubMed ID: 4533399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acute leukaemias with myelofibrosis. Clinical, cytohistological and evolutive aspects. Their place among malignant blood diseases with myelofibrosis (author's transl)].
    Duhamel G; Stachowiak J; Deloux J; Lecomte D; de St Maur P; Najman A; Gorin N
    Nouv Presse Med; 1981 Mar; 10(14):1119-23. PubMed ID: 7220283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Leukocyte alkaline phosphatase and glucose-6-phosphate-dehydrogenase of the erythrocytes in differential diagnosis of chronic myeloproliferative diseases (author's transl)].
    Hennemann HH; Schief A
    Med Klin; 1974 Aug; 69(34):1359-63. PubMed ID: 4530151
    [No Abstract]   [Full Text] [Related]  

  • 56. [What is superfluous in hematologic diagnosis?].
    Schlag R; Thiel E
    Internist (Berl); 1986 Sep; 27(9):591-600. PubMed ID: 3531075
    [No Abstract]   [Full Text] [Related]  

  • 57. Monoester lipase activity in the red cells of patients with various blood disorders.
    Gastaut JA; Vérine A; Crcassonne Y; Boyer J
    Br J Haematol; 1982 Sep; 52(1):127-30. PubMed ID: 7115622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Isoenzymes of fructosephosphate aldolase in the serum of patients with various malignant hemopathies. Isoenzymes of fructosephosphate aldolase. IX].
    Dikow AL; Genova V
    Z Klin Chem Klin Biochem; 1969 Nov; 7(6):614-6. PubMed ID: 4903945
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cytochemical stains of value in hematological diagnosis].
    Lagerlöf B; Sundström C; Ost A
    Lakartidningen; 1979 Dec; 76(49):4495-8. PubMed ID: 94646
    [No Abstract]   [Full Text] [Related]  

  • 60. Diagnostic usefulness of acridine orange in fluorescence microscopy in certain hematological syndromes, particularly in proliferative processes.
    Topolska P; Gürtler-Krawczyńska E
    Pol Med J; 1968; 7(2):372-9. PubMed ID: 5241714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.